Two Sigma Investments’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-77,200
| Closed | -$143K | – | 3341 |
|
|
2023
Q1 | $143K | Buy |
77,200
+24,384
| +46% | +$45.1K | ﹤0.01% | 2544 |
|
|
2022
Q4 | $58.6K | Sell |
52,816
-44,158
| -46% | -$49K | ﹤0.01% | 2516 |
|
|
2022
Q3 | $227K | Sell |
96,974
-36,111
| -27% | -$84.5K | ﹤0.01% | 2017 |
|
|
2022
Q2 | $403K | Buy |
133,085
+67,947
| +104% | +$206K | ﹤0.01% | 1841 |
|
|
2022
Q1 | $442K | Sell |
65,138
-253,413
| -80% | -$1.72M | ﹤0.01% | 2043 |
|
|
2021
Q4 | $2.66M | Buy |
318,551
+95,648
| +43% | +$799K | 0.01% | 1197 |
|
|
2021
Q3 | $1.66M | Sell |
222,903
-74,726
| -25% | -$555K | ﹤0.01% | 1459 |
|
|
2021
Q2 | $2.02M | Buy |
297,629
+202,780
| +214% | +$1.38M | ﹤0.01% | 1319 |
|
|
2021
Q1 | $974K | Buy |
+94,849
| New | +$974K | ﹤0.01% | 1612 |
|
|
2020
Q1 | – | Sell |
-123,919
| Closed | -$1.08M | – | 2542 |
|
|
2019
Q4 | $1.08M | Buy |
123,919
+68,058
| +122% | +$594K | ﹤0.01% | 1378 |
|
|
2019
Q3 | $186K | Sell |
55,861
-39,273
| -41% | -$131K | ﹤0.01% | 1762 |
|
|
2019
Q2 | $471K | Sell |
95,134
-100,124
| -51% | -$496K | ﹤0.01% | 1610 |
|
|
2019
Q1 | $1.21M | Sell |
195,258
-206,674
| -51% | -$1.28M | ﹤0.01% | 1361 |
|
|
2018
Q4 | $1.36M | Buy |
401,932
+80,863
| +25% | +$273K | 0.01% | 1190 |
|
|
2018
Q3 | $2.09M | Buy |
321,069
+117,840
| +58% | +$766K | 0.01% | 1081 |
|
|
2018
Q2 | $1.56M | Buy |
+203,229
| New | +$1.56M | ﹤0.01% | 1179 |
|